SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-066811
Filing Date
2023-03-10
Accepted
2023-03-10 08:05:53
Documents
14
Period of Report
2023-03-10
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d469201d8k.htm   iXBRL 8-K 23617
2 EX-99.1 d469201dex991.htm EX-99.1 49394
6 GRAPHIC g469201dsp14.jpg GRAPHIC 4039
  Complete submission text file 0001193125-23-066811.txt   212314

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA etnb-20230310.xsd EX-101.SCH 2844
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE etnb-20230310_lab.xml EX-101.LAB 18737
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE etnb-20230310_pre.xml EX-101.PRE 11703
8 EXTRACTED XBRL INSTANCE DOCUMENT d469201d8k_htm.xml XML 3464
Mailing Address 142 SANSOME STREET SECOND FLOOR SAN FRANCISCO CA 94104
Business Address 142 SANSOME STREET SECOND FLOOR SAN FRANCISCO CA 94104 (415) 432-9270
89bio, Inc. (Filer) CIK: 0001785173 (see all company filings)

IRS No.: 831114349 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39122 | Film No.: 23721685
SIC: 2834 Pharmaceutical Preparations